DEXLEVO is the first company in Asia to win the BEST injectable award at AMWC, the largest aesthetic anti-aging congress in the world

SEOUL, South Korea, May 12, 2022-(BUSINESS WIRE)-The aesthetic and medical device company DEXLEVO participated in the 20th AMWC (Aesthetic & Anti-aging Medicine World Congress) held in Monaco and explained its products to guests.

This press release contains multimedia elements. See the full press release here: https://www.businesswire.com/news/home/20220502005977/fr/

The aesthetic and medical device company DEXLEVO attended the 20th AMWC (Aesthetic & Anti-aging Medicine World Congress) held in Monaco and explained its products to guests. (Photo: BusinessWire)

GOURI, the first fully liquid PCL (polycaprolactone) injectable, developed by DEXLEVO, an aesthetic and medical device company, was the first in Asia to be selected as Best Injectable in the category at the 20th AMWC (World Medical Congress aesthetics and anti-aging). held in Monaco from March 31 to April 2, 2022.

AMWC is one of the most prestigious aesthetic and anti-aging congresses in the world. More than 20,000 visitors from more than 200 countries around the world, including dermatologists, attend the event each year to share the latest trends in aesthetic and anti-aging products and industry trends.

DEXLEVO launched GOURI, the world’s first all-liquid PCL injectable, at the AMWC Congress in 2021. At its second appearance at AMWC, the company won the Best Injectable award for the first time as an Asian company at the AMWC Awards, and the unique its technology and products are recognized on the world stage. For the AMWC Awards, the AMWC committee reviews and selects candidate products, which are judged by votes from dermatologists and industry workers around the world. In this year’s review, DEXLEVO was nominated along with leading global beauty companies such as Allergan, Merz, Fillmed and Aptos, demonstrating its capability in the global market.

More than 150 doctors and companies visited the DEXLEVO booth and showed great interest in GOURI, which provides a basic solution for anti-aging.

Under the theme of “1st liquid PCL-What, When, Why?” Mexican dermatologist Dr Arturo Vela said, “Today the beauty market is looking for naturalness. DEXLEVO’s GOURI product is the world’s first all-liquid PCL injectable and the safest anti-aging product that meets consumer needs.Dr. Dinko Kaliterna, a Croatian dermatologist, gave a treatment speech at the congress about “Skin Rejuvenation with Liquid PCL”, stating that GOURI is safer than competitive products and its treatment is very convenient. The patient’s satisfaction with the procedure is high due to the regenerative effect of natural collagen. »

An official DEXLEVO representative added, “The beauty market trend is changing and more companies are showing interest compared to AMWC last year. As the global market is increasingly interested in GOURI, we plan to support marketing to become a leader in anti-aging products. »

DEXLEVO’s GOURI product is the world’s first all-liquid polycaprolactone (PCL) injectable PCL, a biodegradable polymeric material that naturally spreads on the face and around the eyes when injected into the skin, forming a three- dimensional matrix and causes collagen production.

With the launch of AMWC in September 2021, DEXLEVO will be selling and supplying GOURI under contract in more than 40 countries and will participate as a platinum promoter at IMCAS 2022, to be held in Paris next June, to facilitate marketing activities and expand presence in the global market.

The text of the press release resulting from a translation should not be considered official. The only true version of the press release is the press release in its original language. The translation always has to be compared to the source text, which will set a precedent.

Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20220502005977/en/

contacts

DEXLEVO
Marketing department
Chris Jeong |
chrisjeong@dexlevo.com

Leave a Comment